Date of Report: June 14, 2006
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
600 North Centennial Street
(Address of principal executive offices)
Registrants telephone number, including area code: (616) 772-1800
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[_] Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b)).
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
|Item 1.01||Entry into a Material Definitive Agreement|
|Gentex Corporation (the Company) previously announced (on April 12, 2006) that Enoch Jen, 54, the Companys Vice President Finance and Chief Financial Officer, was promoted to Senior Vice President and would retain the role of Chief Financial Officer until January 2, 2007, and that on January 2, 2007, Steven Dykman, 40, currently the Companys Treasurer and Director of Accounting and Finance, will assume the role of the Companys Chief Financial Officer.|
|In February 2006, Mr. Jen provided notice of his intent to retire effective January 2, 2007, which the Company announced on February 15, 2006. Based upon an agreement reached and formalized with the Company on June 9, 2006, the Company announced that Mr. Jen now plans to retire as Senior Vice President effective January 2, 2008, and has agreed to work on a part-time consulting basis for the Company through March 31, 2009. Mr. Dykman will still assume the role of the Companys Chief Financial Officer as of January 2, 2007.|
|On June 9, 2006, the Compensation Committee of the Board of Directors of the Company agreed that Mr. Jen will receive a base salary of $210,000, retroactive to April 17, 2006, and that he will remain eligible for a profit-sharing bonus and a discretionary bonus, which bonuses are available to all salaried employees and officers generally and which in operation provide for the same method of allocation of benefits between management and non-management participants. In addition, the Compensation Committee also agreed that Mr. Jen will receive a 25,000-share stock option grant on the date of the next regularly scheduled quarterly Compensation Committee meeting at which grants are made. Any future stock option or restricted stock grants will be made in accordance with the Companys plans at Mr. Jens next regularly scheduled grant date in March of 2007.|
|Mr. Jen has no family relationships with any director or executive officer of the Company. He does not have a written employment agreement and will continue to be an at-will employee as is the case with all employees of the Company.|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|Dated: June 14, 2006||GENTEX CORPORATION
By /s/ Fred Bauer
Its Chairman of the Board and
Chief Executive Officer